Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 24175755)

1.

Microfluidic templated mesoporous silicon-solid lipid microcomposites for sustained drug delivery.

Liu D, Herranz-Blanco B, Mäkilä E, Arriaga LR, Mirza S, Weitz DA, Sandler N, Salonen J, Hirvonen J, Santos HA.

ACS Appl Mater Interfaces. 2013 Nov 27;5(22):12127-34. doi: 10.1021/am403999q. Epub 2013 Nov 13.

PMID:
24175755
2.

Influence of Surface Chemistry on the Release of an Antibacterial Drug from Nanostructured Porous Silicon.

Wang M, Hartman PS, Loni A, Canham LT, Bodiford N, Coffer JL.

Langmuir. 2015 Jun 9;31(22):6179-85. doi: 10.1021/acs.langmuir.5b01372. Epub 2015 May 26.

PMID:
25970551
3.

Zn2+ -Triggered Drug Release from Biocompatible Zirconium MOFs Equipped with Supramolecular Gates.

Tan LL, Li H, Zhou Y, Zhang Y, Feng X, Wang B, Yang YW.

Small. 2015 Apr 28. doi: 10.1002/smll.201500155. [Epub ahead of print]

PMID:
25919865
4.

Recent advances in porous silicon-based therapeutic delivery.

Barnes TJ, Prestidge CA.

Ther Deliv. 2015 Feb;6(2):97-100. doi: 10.4155/tde.14.112. No abstract available.

5.

A microfluidic system for evaluating drug delivery to solid tumors.

Park K.

J Control Release. 2015 Mar 10;201:101. doi: 10.1016/j.jconrel.2015.02.010. No abstract available.

PMID:
25682527
6.

Oxidation-Induced Trapping of Drugs in Porous Silicon Microparticles.

Fry NL, Boss GR, Sailor MJ.

Chem Mater. 2014 Apr 22;26(8):2758-2764. Epub 2014 Mar 20.

7.

Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.

Nieto A, Hou H, Moon SW, Sailor MJ, Freeman WR, Cheng L.

Invest Ophthalmol Vis Sci. 2015 Jan 22;56(2):1070-80. doi: 10.1167/iovs.14-15997.

PMID:
25613937
8.

Controlled fabrication of multicompartmental polymeric microparticles by sequential micromolding via surface-tension-induced droplet formation.

Choi CH, Kang SM, Jin SH, Yi H, Lee CS.

Langmuir. 2015 Feb 3;31(4):1328-35. doi: 10.1021/la504404y. Epub 2015 Jan 16.

PMID:
25551788
9.

Functionalization of alkyne-terminated thermally hydrocarbonized porous silicon nanoparticles with targeting peptides and antifouling polymers: effect on the human plasma protein adsorption.

Wang CF, Mäkilä EM, Bonduelle C, Rytkönen J, Raula J, Almeida S, Närvänen A, Salonen JJ, Lecommandoux S, Hirvonen JT, Santos HA.

ACS Appl Mater Interfaces. 2015 Jan 28;7(3):2006-15. doi: 10.1021/am507827n. Epub 2015 Jan 13.

PMID:
25539741
10.

Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy.

Liu D, Zhang H, Mäkilä E, Fan J, Herranz-Blanco B, Wang CF, Rosa R, Ribeiro AJ, Salonen J, Hirvonen J, Santos HA.

Biomaterials. 2015 Jan;39:249-59. doi: 10.1016/j.biomaterials.2014.10.079. Epub 2014 Nov 20.

PMID:
25468375
11.

Formulation and characterization of hydrochlorothiazide solid lipid microparticles based on lipid matrices of Irvingia fat.

Agubata CO, Chime SA, Kenechukwu FC, Nzekwe IT, Onunkwo GC.

Int J Pharm Investig. 2014 Oct;4(4):189-94. doi: 10.4103/2230-973X.143120.

12.

Mold-templated inorganic-organic hybrid supraparticles for codelivery of drugs.

Maina JW, Cui J, Björnmalm M, Wise AK, Shepherd RK, Caruso F.

Biomacromolecules. 2014 Nov 10;15(11):4146-51. doi: 10.1021/bm501171j. Epub 2014 Oct 16.

PMID:
25321318
13.

In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications.

Mori M, Almeida PV, Cola M, Anselmi G, Mäkilä E, Correia A, Salonen J, Hirvonen J, Caramella C, Santos HA.

Eur J Pharm Biopharm. 2014 Nov;88(3):635-42. doi: 10.1016/j.ejpb.2014.09.010. Epub 2014 Oct 8.

PMID:
25305585
14.

Enhanced cell adhesion to the dimpled surfaces of golf-ball-shaped microparticles.

Lee JH, Lee CS, Cho KY.

ACS Appl Mater Interfaces. 2014 Oct 8;6(19):16493-7. doi: 10.1021/am505997s. Epub 2014 Sep 29.

PMID:
25265359
15.

Formulation, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles.

Ogbonna JD, Kenechukwu FC, Nwobi CS, Chibueze OS, Attama AA.

Pharm Dev Technol. 2014 Aug 18:1-8. [Epub ahead of print]

PMID:
25133606
16.

Electrosprayed inulin microparticles for microbiota triggered targeting of colon.

Jain AK, Sood V, Bora M, Vasita R, Katti DS.

Carbohydr Polym. 2014 Nov 4;112:225-34. doi: 10.1016/j.carbpol.2014.05.087. Epub 2014 Jun 6.

PMID:
25129739
17.

In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.

Tölli MA, Ferreira MP, Kinnunen SM, Rysä J, Mäkilä EM, Szabó Z, Serpi RE, Ohukainen PJ, Välimäki MJ, Correia AM, Salonen JJ, Hirvonen JT, Ruskoaho HJ, Santos HA.

Biomaterials. 2014 Sep;35(29):8394-405. doi: 10.1016/j.biomaterials.2014.05.078. Epub 2014 Jun 28.

PMID:
24985734
18.

In vivo evaluation of porous silicon and porous silicon solid lipid nanocomposites for passive targeting and imaging.

Kallinen AM, Sarparanta MP, Liu D, Mäkilä EM, Salonen JJ, Hirvonen JT, Santos HA, Airaksinen AJ.

Mol Pharm. 2014 Aug 4;11(8):2876-86. doi: 10.1021/mp500225b. Epub 2014 Jul 9.

PMID:
24977922
19.

Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera.

Onyishi IV, Chime SA, Ogudiegwu EO.

Pharm Dev Technol. 2014 Jun 25:1-9. [Epub ahead of print]

PMID:
24964095
20.

Formulation in vitro and in vivo evaluation of SRMS-based heterolipid-templated homolipid delivery system for diclofenac sodium.

Mumuni M, Attama AA, Kunle OO.

Drug Deliv. 2014 Jun 24:1-9. [Epub ahead of print]

PMID:
24959939
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk